ISPOR - RWD170 Real-World Experience of Patients Newly Initiated on Pexidartinib for Tenosynovial Giant Cell Tumor

Full Text

RWD170 Real-World Experience of Patients Newly Initiated on Pexidartinib for Tenosynovial Giant Cell Tumor

Abstract

Authors

D Dai K Tecson I Pan X Ye WD Tap

Back to Volume 27, Supplemental Issue 6S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now